[Close]  
Pharmaceutical market research logo; 24-years of Excellence in Market Research since 1988 roundel.

United Kingdom    France   Germany   Saudi Arabia   Spain

>

The Pharmaceutical Market: Singapore

The Pharmaceutical Market: Singapore

Table of Contents

Management Report
Published: January 2010
Pages: 38
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00  Buy Now!
Research from: Espicom
Sector: Prescription Medicines

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. The standard of living in Singapore is comparable to many developed Western nations and, with the exception of Japan, GDP per capita is the highest of all the Asian countries. The combination of private saving schemes, government subsidies and control has produced a healthcare system that is both universal and affordable. The slowdown in the economy is not expected to affect the quality of the healthcare system.

The ‘Health Products Act 2007’ should improve regulatory practice for both medical devices and pharmaceuticals. Amendments to the Medicines Act have been made in a bid to ensure greater protection of pharmaceutical patents.

Singapore acts as a key trading hub to connect South East Asia and the Western world and is a major re-exporter of pharmaceuticals. The country exports more pharmaceuticals than any other of the Asian Tiger economies by a significant distance, although the majority of this total is from re-exported goods.

Incentives such as low corporate tax rates and strong intellectual property laws have enabled it to secure S$932.4 million (US$618.7 million) in commitments to invest in the biomedical manufacturing industry (pharmaceutical and medical devices) in 2007 alone.

Highly detailed report content

MARKET OUTLOOK
Key national data projections

Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development

Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property

Pharmaceutical distribution

Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.

Top of Page